Should you buy Microvast stock now?
No, the technical signal for Microvast is currently SELL. Microvast trades at $0.82 as of 8/15/2026. The overall technical signal is: Strong Sell. The technical analysis shows the following: MACD is negative (bearish trend) at -0.046 with rising momentum (signal: -0.068); RSI is at 43.1 (neutral zone); the stock is in a short-term downtrend (price below the 20-day average); the analyst price target of $5.50 points to 571.7% upside. The stock is in a broader downtrend (below SMA50/SMA200). Buying in a downtrend is generally not recommended. This is a technical observation based on current data, not investment advice.
What is the price target for Microvast stock?
The average analyst price target for Microvast is $5.50. The current price is $0.82, which gives an upside of 571.7%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $4.95 and $6.05.
Is Microvast a dividend stock?
No, Microvast does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Microvast stock?
Microvast is rated as a stock with extreme risk. the annual standard deviation is 95.4%, which classifies the stock as extreme risk.
Is Microvast overvalued?
No, Microvast is considered undervalued based on the analyst price target (571.7% upside). Microvast has the following valuation ratios: a P/S ratio of 0.9, a P/B ratio of 0.6. The analyst price target suggests that the stock is undervalued by 571.7%.
Is Microvast overbought?
No, Microvast is not overbought. RSI is at 43.1 (neutral zone). The technical indicators show: RSI is at 43.1 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 3.0% below the 20-day average (short-term downtrend). In addition, MACD is negative, but momentum is rising (possible trend reversal).
When is the next Microvast earnings report?
The date of the next earnings report for Microvast has not been published yet. Check the company's investor calendar for updates.
Is Microvast shorted?
Yes, Microvast is shorted with 7.6% of the free float sold short. This is a high level of short selling, which suggests some investors are betting on falling prices. Positive surprises can lead to a moderate short squeeze. Data is updated daily based on official filings with the SEC.
Are insiders buying Microvast stock?
Yes, insiders are net buyers of Microvast – they are buying more shares than they are selling. Over the last 3 months, insiders have made 1 purchases and 4 sales. On a net basis, 24,865,640 $ worth of shares were bought. Across the last 16 reported transactions, the split is 5 purchases and 11 sales, with a net 22,660,590 $ bought. Active buyers include Wu Yang, Webster Craig, Smith Shane. Insider buying is generally seen as a positive signal, because management is putting its own money into the company.
Is Microvast a good stock?
We do not yet have enough data to give Microvast an overall rating. In addition: analysts see 571.7% upside to the price target; technical signal: Strong Sell. Whether Microvast is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Microvast stock?
The outlook for Microvast based on current data: the average analyst price target is $5.50 (+571.7%); the stock is in a downtrend (below SMA50 and SMA200). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Microvast stock falling?
Microvast is falling right now. The technical indicators show: the price is 3.0% below the 20-day average; short interest is 7.6% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can Microvast go?
The average analyst price target for Microvast is $5.50, which corresponds to a potential gain of 571.7% from the current price of $0.82. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Microvast fall?
We lack enough history to give a specific floor for Microvast. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Microvast do?
Microvast Holdings, Inc. engages in the design, development, and manufacturing of battery components and systems primarily for electric commercial vehicles and energy storage systems. The company offers a range of cell chemistries, such as lithium titanate oxide, lithium iron ... The company belongs to the Consumer Cyclical sector, more specifically the Auto Parts industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Microvast as an investment.
Did Microvast raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Microvast. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Microvast making money or losing money?
Yes, Microvast is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 14.0% — which is solid. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can Microvast go bankrupt?
The bankruptcy risk of Microvast is rated as elevated. Altman Z2 (a model for assessing financial distress) is -2.41 — that places the company in the weak zone. This is a probability based on the numbers, not a verdict — bankruptcy is not imminent. But the balance sheet is measurably weaker than average, so watch the debt, liquidity and possible capital raises. The Piotroski score (financial health 0-9, higher is better) is 5 — which is average. Debt relative to equity is 145% (moderate). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Microvast have a lot of debt?
Microvast has moderate debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 145%. For the consumer cyclical sector, 100-200% counts as a typical level. Cyclical consumer companies can carry moderate debt in good times — high debt is risky in downturns. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.